Global Intravenous Antibodies Market Growth 2021-2027
According to this latest study, the 2021 growth of Intravenous Antibodies will have significant change from previous year. By the most conservative estimates of global Intravenous Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Intravenous Antibodies market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2027.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Antibodies market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2027 in section 11.7.
IgG
IgA
IgM
IgE
IgD
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2027 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Baxter International
CSL Limited
Biotest AG
OMRIX Biopharmaceuticals
Octapharma AG
Grifols, S.A
Guizhou Taibang Biological Products
Shanghai RAAS Blood Products
Hualan Biological Engineering
Kedrion S.p.A.
Beijing Tiantan Biological Products
China Biologic Products
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Antibodies Consumption 2016-2026
2.1.2 Intravenous Antibodies Consumption CAGR by Region
2.2 Intravenous Antibodies Segment by Type
2.2.1 IgG
2.2.2 IgA
2.2.3 IgM
2.2.4 IgE
2.2.5 IgD
2.3 Intravenous Antibodies Sales by Type
2.3.1 Global Intravenous Antibodies Sales Market Share by Type (2016-2021)
2.3.2 Global Intravenous Antibodies Revenue and Market Share by Type (2016-2021)
2.3.3 Global Intravenous Antibodies Sale Price by Type (2016-2021)
2.4 Intravenous Antibodies Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Intravenous Antibodies Sales by Application
2.5.1 Global Intravenous Antibodies Sale Market Share by Application (2016-2021)
2.5.2 Global Intravenous Antibodies Revenue and Market Share by Application (2016-2021)
2.5.3 Global Intravenous Antibodies Sale Price by Application (2016-2021)
3 Global Intravenous Antibodies by Company
3.1 Global Intravenous Antibodies Sales Market Share by Company
3.1.1 Global Intravenous Antibodies Sales by Company (2019-2021)
3.1.2 Global Intravenous Antibodies Sales Market Share by Company (2019-2021)
3.2 Global Intravenous Antibodies Revenue Market Share by Company
3.2.1 Global Intravenous Antibodies Revenue by Company (2019-2021)
3.2.2 Global Intravenous Antibodies Revenue Market Share by Company (2019-2021)
3.3 Global Intravenous Antibodies Sale Price by Company
3.4 Global Manufacturers Intravenous Antibodies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Antibodies Product Location Distribution
3.4.2 Players Intravenous Antibodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Intravenous Antibodies by Region
4.1 Global Intravenous Antibodies by Region
4.1.1 Global Intravenous Antibodies Sales by Region
4.1.2 Global Intravenous Antibodies Revenue by Region
4.2 Americas Intravenous Antibodies Sales Growth
4.3 APAC Intravenous Antibodies Sales Growth
4.4 Europe Intravenous Antibodies Sales Growth
4.5 Middle East & Africa Intravenous Antibodies Sales Growth
5 Americas
5.1 Americas Intravenous Antibodies Sales by Country
5.1.1 Americas Intravenous Antibodies Sales by Country (2016-2021)
5.1.2 Americas Intravenous Antibodies Revenue by Country (2016-2021)
5.2 Americas Intravenous Antibodies Sales by Type
5.3 Americas Intravenous Antibodies Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Antibodies Sales by Region
6.1.1 APAC Intravenous Antibodies Sales by Region (2016-2021)
6.1.2 APAC Intravenous Antibodies Revenue by Region (2016-2021)
6.2 APAC Intravenous Antibodies Sales by Type
6.3 APAC Intravenous Antibodies Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Intravenous Antibodies by Country
7.1.1 Europe Intravenous Antibodies Sales by Country (2016-2021)
7.1.2 Europe Intravenous Antibodies Revenue by Country (2016-2021)
7.2 Europe Intravenous Antibodies Sales by Type
7.3 Europe Intravenous Antibodies Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Antibodies by Country
8.1.1 Middle East & Africa Intravenous Antibodies Sales by Country (2016-2021)
8.1.2 Middle East & Africa Intravenous Antibodies Revenue by Country (2016-2021)
8.2 Middle East & Africa Intravenous Antibodies Sales by Type
8.3 Middle East & Africa Intravenous Antibodies Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Intravenous Antibodies Distributors
10.3 Intravenous Antibodies Customer
11 Global Intravenous Antibodies Market Forecast
11.1 Global Intravenous Antibodies Forecast by Region
11.1.1 Global Intravenous Antibodies Forecast by Regions (2021-2026)
11.2.2 Global Intravenous Antibodies Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Intravenous Antibodies Forecast by Type
11.7 Global Intravenous Antibodies Forecast by Application
12 Key Players Analysis
12.1 Baxter International
12.1.1 Baxter International Company Information
12.1.2 Baxter International Intravenous Antibodies Product Offered
12.1.3 Baxter International Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Baxter International Main Business Overview
12.1.5 Baxter International Latest Developments
12.2 CSL Limited
12.2.1 CSL Limited Company Information
12.2.2 CSL Limited Intravenous Antibodies Product Offered
12.2.3 CSL Limited Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 CSL Limited Main Business Overview
12.2.5 CSL Limited Latest Developments
12.3 Biotest AG
12.3.1 Biotest AG Company Information
12.3.2 Biotest AG Intravenous Antibodies Product Offered
12.3.3 Biotest AG Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Biotest AG Main Business Overview
12.3.5 Biotest AG Latest Developments
12.4 OMRIX Biopharmaceuticals
12.4.1 OMRIX Biopharmaceuticals Company Information
12.4.2 OMRIX Biopharmaceuticals Intravenous Antibodies Product Offered
12.4.3 OMRIX Biopharmaceuticals Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 OMRIX Biopharmaceuticals Main Business Overview
12.4.5 OMRIX Biopharmaceuticals Latest Developments
12.5 Octapharma AG
12.5.1 Octapharma AG Company Information
12.5.2 Octapharma AG Intravenous Antibodies Product Offered
12.5.3 Octapharma AG Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Octapharma AG Main Business Overview
12.5.5 Octapharma AG Latest Developments
12.6 Grifols, S.A
12.6.1 Grifols, S.A Company Information
12.6.2 Grifols, S.A Intravenous Antibodies Product Offered
12.6.3 Grifols, S.A Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Grifols, S.A Main Business Overview
12.6.5 Grifols, S.A Latest Developments
12.7 Guizhou Taibang Biological Products
12.7.1 Guizhou Taibang Biological Products Company Information
12.7.2 Guizhou Taibang Biological Products Intravenous Antibodies Product Offered
12.7.3 Guizhou Taibang Biological Products Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Guizhou Taibang Biological Products Main Business Overview
12.7.5 Guizhou Taibang Biological Products Latest Developments
12.8 Shanghai RAAS Blood Products
12.8.1 Shanghai RAAS Blood Products Company Information
12.8.2 Shanghai RAAS Blood Products Intravenous Antibodies Product Offered
12.8.3 Shanghai RAAS Blood Products Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Shanghai RAAS Blood Products Main Business Overview
12.8.5 Shanghai RAAS Blood Products Latest Developments
12.9 Hualan Biological Engineering
12.9.1 Hualan Biological Engineering Company Information
12.9.2 Hualan Biological Engineering Intravenous Antibodies Product Offered
12.9.3 Hualan Biological Engineering Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Hualan Biological Engineering Main Business Overview
12.9.5 Hualan Biological Engineering Latest Developments
12.10 Kedrion S.p.A.
12.10.1 Kedrion S.p.A. Company Information
12.10.2 Kedrion S.p.A. Intravenous Antibodies Product Offered
12.10.3 Kedrion S.p.A. Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Kedrion S.p.A. Main Business Overview
12.10.5 Kedrion S.p.A. Latest Developments
12.11 Beijing Tiantan Biological Products
12.11.1 Beijing Tiantan Biological Products Company Information
12.11.2 Beijing Tiantan Biological Products Intravenous Antibodies Product Offered
12.11.3 Beijing Tiantan Biological Products Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Beijing Tiantan Biological Products Main Business Overview
12.11.5 Beijing Tiantan Biological Products Latest Developments
12.12 China Biologic Products
12.12.1 China Biologic Products Company Information
12.12.2 China Biologic Products Intravenous Antibodies Product Offered
12.12.3 China Biologic Products Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 China Biologic Products Main Business Overview
12.12.5 China Biologic Products Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Intravenous Antibodies Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of IgG
Table 3. Major Players of IgA
Table 4. Major Players of IgM
Table 5. Major Players of IgE
Table 6. Major Players of IgD
Table 7. Global Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 8. Global Intravenous Antibodies Sales Market Share by Type (2016-2021)
Table 9. Global Intravenous Antibodies Revenue by Type (2016-2021) & ($ million)
Table 10. Global Intravenous Antibodies Revenue Market Share by Type (2016-2021)
Table 11. Global Intravenous Antibodies Sale Price by Type (2016-2021)
Table 12. Global Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 13. Global Intravenous Antibodies Sales Market Share by Application (2016-2021)
Table 14. Global Intravenous Antibodies Value by Application (2016-2021)
Table 15. Global Intravenous Antibodies Revenue Market Share by Application (2016-2021)
Table 16. Global Intravenous Antibodies Sale Price by Application (2016-2021)
Table 17. Global Intravenous Antibodies Sales by Company (2019-2021) & (K Units)
Table 18. Global Intravenous Antibodies Sales Market Share by Company (2019-2021)
Table 19. Global Intravenous Antibodies Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Intravenous Antibodies Revenue Market Share by Company (2019-2021)
Table 21. Global Intravenous Antibodies Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Intravenous Antibodies Producing Area Distribution and Sales Area
Table 23. Players Intravenous Antibodies Products Offered
Table 24. Intravenous Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Intravenous Antibodies Sales by Region (2016-2021) (K Units)
Table 28. Global Intravenous Antibodies Sales Market Share by Region (2016-2021)
Table 29. Global Intravenous Antibodies Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Intravenous Antibodies Revenue Market Share by Region (2016-2021)
Table 31. Americas Intravenous Antibodies Sales by Country (2016-2021) & (K Units)
Table 32. Americas Intravenous Antibodies Sales Market Share by Country (2016-2021)
Table 33. Americas Intravenous Antibodies Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Intravenous Antibodies Revenue Market Share by Country (2016-2021)
Table 35. Americas Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 36. Americas Intravenous Antibodies Sales Market Share by Type (2016-2021)
Table 37. Americas Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 38. Americas Intravenous Antibodies Sales Market Share by Application (2016-2021)
Table 39. APAC Intravenous Antibodies Sales by Region (2016-2021) & (K Units)
Table 40. APAC Intravenous Antibodies Sales Market Share by Region (2016-2021)
Table 41. APAC Intravenous Antibodies Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Intravenous Antibodies Revenue Market Share by Region (2016-2021)
Table 43. APAC Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 44. APAC Intravenous Antibodies Sales Market Share by Type (2016-2021)
Table 45. APAC Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 46. APAC Intravenous Antibodies Sales Market Share by Application (2016-2021)
Table 47. Europe Intravenous Antibodies Sales by Country (2016-2021) & (K Units)
Table 48. Europe Intravenous Antibodies Sales Market Share by Country (2016-2021)
Table 49. Europe Intravenous Antibodies Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Intravenous Antibodies Revenue Market Share by Country (2016-2021)
Table 51. Europe Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 52. Europe Intravenous Antibodies Sales Market Share by Type (2016-2021)
Table 53. Europe Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 54. Europe Intravenous Antibodies Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Intravenous Antibodies Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Intravenous Antibodies Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Intravenous Antibodies Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Intravenous Antibodies Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Intravenous Antibodies Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Intravenous Antibodies Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Intravenous Antibodies
Table 64. Key Application and Potential Industries of Intravenous Antibodies
Table 65. Key Challenges of Intravenous Antibodies
Table 66. Key Trends of Intravenous Antibodies
Table 67. Intravenous Antibodies Distributors List
Table 68. Intravenous Antibodies Customer List
Table 69. Global Intravenous Antibodies Sales Forecast by Region (2021-2026) & (K Units)
Table 70. Global Intravenous Antibodies Consumption Market Forecast by Region
Table 71. Global Intravenous Antibodies Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Intravenous Antibodies Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Intravenous Antibodies Sales Forecast by Country (2021-2026) & (K Units)
Table 74. Americas Intravenous Antibodies Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Intravenous Antibodies Sales Forecast by Region (2021-2026) & (K Units)
Table 76. APAC Intravenous Antibodies Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Intravenous Antibodies Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Europe Intravenous Antibodies Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Intravenous Antibodies Sales Forecast by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Intravenous Antibodies Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Intravenous Antibodies Sales Forecast by Type (2021-2026) & (K Units)
Table 82. Global Intravenous Antibodies Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Intravenous Antibodies Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Intravenous Antibodies Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Intravenous Antibodies Sales Forecast by Application (2021-2026) & (K Units)
Table 86. Global Intravenous Antibodies Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Intravenous Antibodies Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Intravenous Antibodies Revenue Market Share Forecast by Application (2021-2026)
Table 89. Baxter International Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 90. Baxter International Intravenous Antibodies Product Offered
Table 91. Baxter International Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. Baxter International Main Business
Table 93. Baxter International Latest Developments
Table 94. CSL Limited Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 95. CSL Limited Intravenous Antibodies Product Offered
Table 96. CSL Limited Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. CSL Limited Main Business
Table 98. CSL Limited Latest Developments
Table 99. Biotest AG Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 100. Biotest AG Intravenous Antibodies Product Offered
Table 101. Biotest AG Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. Biotest AG Main Business
Table 103. Biotest AG Latest Developments
Table 104. OMRIX Biopharmaceuticals Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 105. OMRIX Biopharmaceuticals Intravenous Antibodies Product Offered
Table 106. OMRIX Biopharmaceuticals Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. OMRIX Biopharmaceuticals Main Business
Table 108. OMRIX Biopharmaceuticals Latest Developments
Table 109. Octapharma AG Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 110. Octapharma AG Intravenous Antibodies Product Offered
Table 111. Octapharma AG Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Octapharma AG Main Business
Table 113. Octapharma AG Latest Developments
Table 114. Grifols, S.A Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 115. Grifols, S.A Intravenous Antibodies Product Offered
Table 116. Grifols, S.A Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Grifols, S.A Main Business
Table 118. Grifols, S.A Latest Developments
Table 119. Guizhou Taibang Biological Products Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 120. Guizhou Taibang Biological Products Intravenous Antibodies Product Offered
Table 121. Guizhou Taibang Biological Products Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 122. Guizhou Taibang Biological Products Main Business
Table 123. Guizhou Taibang Biological Products Latest Developments
Table 124. Shanghai RAAS Blood Products Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 125. Shanghai RAAS Blood Products Intravenous Antibodies Product Offered
Table 126. Shanghai RAAS Blood Products Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 127. Shanghai RAAS Blood Products Main Business
Table 128. Shanghai RAAS Blood Products Latest Developments
Table 129. Hualan Biological Engineering Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 130. Hualan Biological Engineering Intravenous Antibodies Product Offered
Table 131. Hualan Biological Engineering Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 132. Hualan Biological Engineering Main Business
Table 133. Hualan Biological Engineering Latest Developments
Table 134. Kedrion S.p.A. Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 135. Kedrion S.p.A. Intravenous Antibodies Product Offered
Table 136. Kedrion S.p.A. Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 137. Kedrion S.p.A. Main Business
Table 138. Kedrion S.p.A. Latest Developments
Table 139. Beijing Tiantan Biological Products Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 140. Beijing Tiantan Biological Products Intravenous Antibodies Product Offered
Table 141. Beijing Tiantan Biological Products Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 142. Beijing Tiantan Biological Products Main Business
Table 143. Beijing Tiantan Biological Products Latest Developments
Table 144. China Biologic Products Basic Information, Intravenous Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 145. China Biologic Products Intravenous Antibodies Product Offered
Table 146. China Biologic Products Intravenous Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 147. China Biologic Products Main Business
Table 148. China Biologic Products Latest Developments
List of Figures
Figure 1. Picture of Intravenous Antibodies
Figure 2. Intravenous Antibodies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Antibodies Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Intravenous Antibodies Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Intravenous Antibodies Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of IgG
Figure 10. Product Picture of IgA
Figure 11. Product Picture of IgM
Figure 12. Product Picture of IgE
Figure 13. Product Picture of IgD
Figure 14. Global Intravenous Antibodies Sales Market Share by Type in 2020
Figure 15. Global Intravenous Antibodies Revenue Market Share by Type (2016-2021)
Figure 16. Intravenous Antibodies Consumed in Hospitals
Figure 17. Global Intravenous Antibodies Market: Hospitals (2016-2021) & (K Units)
Figure 18. Intravenous Antibodies Consumed in Clinics
Figure 19. Global Intravenous Antibodies Market: Clinics (2016-2021) & (K Units)
Figure 20. Intravenous Antibodies Consumed in Others
Figure 21. Global Intravenous Antibodies Market: Others (2016-2021) & (K Units)
Figure 22. Global Intravenous Antibodies Sales Market Share by Application (2016-2021)
Figure 23. Global Intravenous Antibodies Revenue Market Share by Application in 2020
Figure 24. Intravenous Antibodies Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Intravenous Antibodies Revenue Market Share by Company in 2020
Figure 26. Global Intravenous Antibodies Sales Market Share by Regions (2016-2021)
Figure 27. Global Intravenous Antibodies Revenue Market Share by Region in 2020
Figure 28. Americas Intravenous Antibodies Sales 2016-2021 (K Units)
Figure 29. Americas Intravenous Antibodies Revenue 2016-2021 ($ Millions)
Figure 30. APAC Intravenous Antibodies Sales 2016-2021 (K Units)
Figure 31. APAC Intravenous Antibodies Revenue 2016-2021 ($ Millions)
Figure 32. Europe Intravenous Antibodies Sales 2016-2021 (K Units)
Figure 33. Europe Intravenous Antibodies Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Intravenous Antibodies Sales 2016-2021 (K Units)
Figure 35. Middle East & Africa Intravenous Antibodies Revenue 2016-2021 ($ Millions)
Figure 36. Americas Intravenous Antibodies Sales Market Share by Country in 2020
Figure 37. Americas Intravenous Antibodies Revenue Market Share by Country in 2020
Figure 38. Americas Intravenous Antibodies Sales Market Share by Type in 2020
Figure 39. Americas Intravenous Antibodies Sales Market Share by Application in 2020
Figure 40. United States Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Intravenous Antibodies Sales Market Share by Region in 2020
Figure 45. APAC Intravenous Antibodies Revenue Market Share by Regions in 2020
Figure 46. APAC Intravenous Antibodies Sales Market Share by Type in 2020
Figure 47. APAC Intravenous Antibodies Sales Market Share by Application in 2020
Figure 48. China Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Intravenous Antibodies Sales Market Share by Country in 2020
Figure 55. Europe Intravenous Antibodies Revenue Market Share by Country in 2020
Figure 56. Europe Intravenous Antibodies Sales Market Share by Type in 2020
Figure 57. Europe Intravenous Antibodies Sales Market Share by Application in 2020
Figure 58. Germany Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Intravenous Antibodies Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Intravenous Antibodies Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Intravenous Antibodies Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Intravenous Antibodies Sales Market Share by Application in 2020
Figure 67. Egypt Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Intravenous Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
